Weller C, Bartok O, McGinnis CS, Palashati H, Chang TG, Malko D, Shmueli MD, Nagao A, Hayoun D, Murayama A, Sakaguchi Y, Poulis P, Khatib A, Erlanger Avigdor B, Gordon S, Cohen Shvefel S, Zemanek MJ, Nielsen MM, Boura-Halfon S, Sagie S, Gumpert N, Yang W, Alexeev D, Kyriakidou P, Yao Wet al.(2025) Translation dysregulation in cancer as a source for targetable antigens Cancer Cell(in press) DOI 10.1016/j.ccell.2025.03.003, PubMed 40154482
Champagne J, Nielsen MM, Feng X, Montenegro Navarro J, Pataskar A, Voogd R, Giebel L, Nagel R, Berenst N, Fumagalli A, Kochavi A, Lovecchio D, Valcanover L, Malka Y, Yang W, Laos M, Li Y, Proost N, van de Ven M, van Tellingen O, Bleijerveld OB, Haanen JBAG, Olweus J, Agami R(2025) Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation Immunity, 58(1), 247-262.e9 DOI 10.1016/j.immuni.2024.12.004, PubMed 39755122
